These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7918425)

  • 1. Evidence for conformational dynamics and molecular aggregation in cytochrome P450 102 (BM-3).
    Black SD; Martin ST
    Biochemistry; 1994 Oct; 33(40):12056-62. PubMed ID: 7918425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affinity isolation and characterization of cytochrome P450 102 (BM-3) from barbiturate-induced Bacillus megaterium.
    Black SD; Linger MH; Freck LC; Kazemi S; Galbraith JA
    Arch Biochem Biophys; 1994 Apr; 310(1):126-33. PubMed ID: 8161195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Truncated human P450 2D6: expression in Escherichia coli, Ni(2+)-chelate affinity purification, and characterization of solubility and aggregation.
    Kempf AC; Zanger UM; Meyer UA
    Arch Biochem Biophys; 1995 Aug; 321(2):277-88. PubMed ID: 7646052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
    Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
    Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deflavination of cytochrome P450 BM3 by treatment with guanidinium chloride.
    Munro AW; Coggins JR; Lindsay JG; Kelly S; Price NC
    Biochem Soc Trans; 1996 Feb; 24(1):19S. PubMed ID: 8674659
    [No Abstract]   [Full Text] [Related]  

  • 6. Obligatory intermolecular electron-transfer from FAD to FMN in dimeric P450BM-3.
    Kitazume T; Haines DC; Estabrook RW; Chen B; Peterson JA
    Biochemistry; 2007 Oct; 46(42):11892-901. PubMed ID: 17902705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the domain structure of cytochrome P450 102 (BM-3): isolation and properties of a 45-kDa FAD/NADP domain.
    Black SD
    Biochem Biophys Res Commun; 1994 Aug; 203(1):162-8. PubMed ID: 8074651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein engineering of the cytochrome P450 monooxygenase from Bacillus megaterium.
    Urlacher VB; Schmid RD
    Methods Enzymol; 2004; 388():208-24. PubMed ID: 15289074
    [No Abstract]   [Full Text] [Related]  

  • 9. Resonance Raman spectroscopic studies on intact cytochrome P450 BM3.
    Munro AW; Lindsay JG; Coggins JR; MacDonald I; Smith WE; Rospendowski BN
    Biochem Soc Trans; 1994 Feb; 22(1):54S. PubMed ID: 8206282
    [No Abstract]   [Full Text] [Related]  

  • 10. Regional saturation mutagenesis as an approach to identification of substrate specificity determinants in cytochrome P450 BM3.
    Munro AW; Coggins JR; Lindsay JG
    Biochem Soc Trans; 1993 Nov; 21(4):409S. PubMed ID: 8131983
    [No Abstract]   [Full Text] [Related]  

  • 11. Residue size at position 87 of cytochrome P450 BM-3 determines its stereoselectivity in propylbenzene and 3-chlorostyrene oxidation.
    Li QS; Ogawa J; Schmid RD; Shimizu S
    FEBS Lett; 2001 Nov; 508(2):249-52. PubMed ID: 11718725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification schemes for the constituent domains of cytochrome P450 BM3 in E. coli.
    Munro AW
    Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):316S. PubMed ID: 8224461
    [No Abstract]   [Full Text] [Related]  

  • 13. The bacterial P450 BM3: a prototype for a biocatalyst with human P450 activities.
    Yun CH; Kim KH; Kim DH; Jung HC; Pan JG
    Trends Biotechnol; 2007 Jul; 25(7):289-98. PubMed ID: 17532492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
    Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
    J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure, dynamics, and function of the monooxygenase P450 BM-3: insights from computer simulations studies.
    Roccatano D
    J Phys Condens Matter; 2015 Jul; 27(27):273102. PubMed ID: 26061496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic probes of flavocytochrome P-450 BM3.
    Noble MA; Turner KL; Chapman SK; Munro AW
    Biochem Soc Trans; 1998 Aug; 26(3):S213. PubMed ID: 9765932
    [No Abstract]   [Full Text] [Related]  

  • 17. Catalytically self-sufficient P450 CYP102 (cytochrome P450 BM-3): resonance Raman spectral characterization of the heme domain and of the holoenzyme.
    Hudeèek J; Baumruk V; Anzenbacher P; Munro AW
    Biochem Biophys Res Commun; 1998 Feb; 243(3):811-5. PubMed ID: 9500975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of kinetic isotope effects to delineate the role of phenylalanine 87 in P450(BM-3).
    Rock DA; Boitano AE; Wahlstrom JL; Rock DA; Jones JP
    Bioorg Chem; 2002 Apr; 30(2):107-18. PubMed ID: 12020135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are branched chain fatty acids the natural substrates for P450(BM3)?
    Cryle MJ; Espinoza RD; Smith SJ; Matovic NJ; De Voss JJ
    Chem Commun (Camb); 2006 Jun; (22):2353-5. PubMed ID: 16733577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusarium oxysporum fatty-acid subterminal hydroxylase (CYP505) is a membrane-bound eukaryotic counterpart of Bacillus megaterium cytochrome P450BM3.
    Kitazume T; Takaya N; Nakayama N; Shoun H
    J Biol Chem; 2000 Dec; 275(50):39734-40. PubMed ID: 10995755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.